Dr. Donald Ira Abrams, MD

Dr. Abrams practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Abrams' NPI, 1679530018, was assigned on April 28, 2006. Dr. Abrams graduated from Stanford University School Of Medicine in 1977. Dr. Abrams holds California license G36948.

Dr. Abrams' primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Abrams' primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Abrams to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abrams practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Abrams' primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Abrams is board certified in internal medicine by the American Board of Internal Medicine. Dr. Abrams is licensed in California.

Dmand AI lists lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Abrams treats.

CMS data shows 258 Medicare services from Dr. Abrams across 6 procedure codes in 2024, for 151 Medicare patients. Medicare paid $18,728 for them.

CMS counts 151 Medicare patients who saw Dr. Abrams in 2024. The largest group is 65 to 74, with 100 patients. 72% of them have cancer, and 60% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abrams' median patient age at 60, with 53% women.

In 2019, Dr. Abrams wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $112,092 in total drug cost. In 2018, CMS named 30 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Abrams for performance year 2024, reported as part of a group. Dr. Abrams accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abrams as offering telehealth.

Dmand AI links 141 papers to Dr. Abrams, published from 2003 to 2025. 2016 was the busiest year, with 3. The most frequent topics are Acquired Immunodeficiency Syndrome, HIV Infections and CD4 Lymphocyte Count. Dr. Abrams has published most often in AIDS. Dr. Abrams' most frequent co-authors are Paul A. Volberding, MD, Lawrence D. Kaplan, MD and Dobri D. Kiprov, MD, PC.

Dmand AI links Dr. Abrams to 9 clinical trials, 4 of them phase 1/2 studies. Conditions studied include HIV Infections, Acquired Immunodeficiency Syndrome and AIDS-Related Opportunistic Infections. Center for Medicinal Cannabis Research sponsors the most, 3.

CMS Open Payments shows 11 general payments to Dr. Abrams from 5 drug and device companies from 2016 to 2021. Consulting fees make up the largest share, 53% of the total. INSYS Therapeutics Inc paid the most, $10,043.

Dmand AI lists 3 awards for Dr. Abrams, most recently America's Top Doctors in 2014.

Dr. Abrams graduated from Stanford University School Of Medicine in 1977. Dr. Abrams is a member of ASCO.

Dr. Abrams is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.